Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab (Pembro) plus Carboplatin and Etoposide Chemotherapy (Chemo) or Chemo Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)
Loading...
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Description
Keywords
Fields of Science
Citation
WoS Q
Scopus Q
Source
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2025 -- Chicago, IL
Volume
43
Issue
16_SUPPL
Start Page
5059
End Page
5059
